JPMorgan Chase & Co’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $544K | Sell |
26,663
-3,914
| -13% | -$79.9K | ﹤0.01% | 4022 |
|
2025
Q1 | $612K | Sell |
30,577
-77,359
| -72% | -$1.55M | ﹤0.01% | 3907 |
|
2024
Q4 | $2.88M | Buy |
107,936
+38,527
| +56% | +$1.03M | ﹤0.01% | 3165 |
|
2024
Q3 | $1.98M | Buy |
69,409
+43,241
| +165% | +$1.23M | ﹤0.01% | 3273 |
|
2024
Q2 | $570K | Sell |
26,168
-49,975
| -66% | -$1.09M | ﹤0.01% | 3797 |
|
2024
Q1 | $1.69M | Buy |
76,143
+25,777
| +51% | +$571K | ﹤0.01% | 3258 |
|
2023
Q4 | $1.09M | Sell |
50,366
-2,297
| -4% | -$49.6K | ﹤0.01% | 3485 |
|
2023
Q3 | $889K | Buy |
52,663
+1,165
| +2% | +$19.7K | ﹤0.01% | 3453 |
|
2023
Q2 | $707K | Buy |
51,498
+7,170
| +16% | +$98.4K | ﹤0.01% | 3604 |
|
2023
Q1 | $1.01M | Buy |
44,328
+8,930
| +25% | +$203K | ﹤0.01% | 3447 |
|
2022
Q4 | $833K | Buy |
35,398
+2,449
| +7% | +$57.6K | ﹤0.01% | 3471 |
|
2022
Q3 | $860K | Buy |
32,949
+2,826
| +9% | +$73.8K | ﹤0.01% | 3455 |
|
2022
Q2 | $661K | Buy |
30,123
+5,799
| +24% | +$127K | ﹤0.01% | 3723 |
|
2022
Q1 | $1.09M | Buy |
24,324
+754
| +3% | +$33.8K | ﹤0.01% | 3552 |
|
2021
Q4 | $1.01M | Buy |
23,570
+1,477
| +7% | +$63.3K | ﹤0.01% | 3665 |
|
2021
Q3 | $1.47M | Buy |
22,093
+4,899
| +28% | +$326K | ﹤0.01% | 3369 |
|
2021
Q2 | $1.26M | Sell |
17,194
-15,078
| -47% | -$1.11M | ﹤0.01% | 3503 |
|
2021
Q1 | $2.21M | Buy |
32,272
+9,802
| +44% | +$671K | ﹤0.01% | 3184 |
|
2020
Q4 | $1.51M | Buy |
22,470
+13,903
| +162% | +$934K | ﹤0.01% | 3147 |
|
2020
Q3 | $433K | Sell |
8,567
-1,698
| -17% | -$85.8K | ﹤0.01% | 3440 |
|
2020
Q2 | $387K | Sell |
10,265
-2,277
| -18% | -$85.8K | ﹤0.01% | 3393 |
|
2020
Q1 | $374K | Buy |
12,542
+10,855
| +643% | +$324K | ﹤0.01% | 3424 |
|
2019
Q4 | $58K | Buy |
1,687
+476
| +39% | +$16.4K | ﹤0.01% | 4189 |
|
2019
Q3 | $22K | Buy |
+1,211
| New | +$22K | ﹤0.01% | 4462 |
|